Cargando…
Defining the commercial determinants of health: a systematic review
BACKGROUND: Despite increasing attention to the social determinants of health in recent decades, globally there is an unprecedented burden from non-communicable diseases (NCDs). Recently, the corporate and commercial conditions associated with these, commercial determinants of health (CDoH), have al...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325018/ https://www.ncbi.nlm.nih.gov/pubmed/32600398 http://dx.doi.org/10.1186/s12889-020-09126-1 |
_version_ | 1783552072519516160 |
---|---|
author | de Lacy-Vawdon, Cassandra Livingstone, Charles |
author_facet | de Lacy-Vawdon, Cassandra Livingstone, Charles |
author_sort | de Lacy-Vawdon, Cassandra |
collection | PubMed |
description | BACKGROUND: Despite increasing attention to the social determinants of health in recent decades, globally there is an unprecedented burden from non-communicable diseases (NCDs). Recently, the corporate and commercial conditions associated with these, commercial determinants of health (CDoH), have also begun to receive attention. This research aims to articulate the CDoH as described in the literature, summarize substantive findings, and assess strengths and limitations of current literature. METHODS: Systematic review of formal (Medline, EMBASE, Scopus, Global Health) and grey literature (database, Google Advanced, targeted website, citation searching). Searching identified 125 texts for full-text review, with 33 included for final review. Data extracted were analyzed thematically. RESULTS: The dynamics constituting CDoH include broad facilitators such as globalization of trade, corporate structures, and regulatory systems, articulation of social and economic power, neoliberal and capitalist ideologies; additional elements include corporate activities such as marketing, corporate political activities, corporate social responsibility, extensive supply chains, harmful products and production, and issues of accessibility. These contribute significantly to worsened global health outcomes. CONCLUSIONS: Literature describing effects of macro conditions and corporate activities on health could usefully utilize CDoH terminology. Facilitation via revised, consistent and operational definition of CDoH would assist. Social, political, commercial and economic structures and relations of CDoH are under-theorized. Systematic approaches to identifying, describing, and disrupting these are required to improve global health. |
format | Online Article Text |
id | pubmed-7325018 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-73250182020-06-30 Defining the commercial determinants of health: a systematic review de Lacy-Vawdon, Cassandra Livingstone, Charles BMC Public Health Research Article BACKGROUND: Despite increasing attention to the social determinants of health in recent decades, globally there is an unprecedented burden from non-communicable diseases (NCDs). Recently, the corporate and commercial conditions associated with these, commercial determinants of health (CDoH), have also begun to receive attention. This research aims to articulate the CDoH as described in the literature, summarize substantive findings, and assess strengths and limitations of current literature. METHODS: Systematic review of formal (Medline, EMBASE, Scopus, Global Health) and grey literature (database, Google Advanced, targeted website, citation searching). Searching identified 125 texts for full-text review, with 33 included for final review. Data extracted were analyzed thematically. RESULTS: The dynamics constituting CDoH include broad facilitators such as globalization of trade, corporate structures, and regulatory systems, articulation of social and economic power, neoliberal and capitalist ideologies; additional elements include corporate activities such as marketing, corporate political activities, corporate social responsibility, extensive supply chains, harmful products and production, and issues of accessibility. These contribute significantly to worsened global health outcomes. CONCLUSIONS: Literature describing effects of macro conditions and corporate activities on health could usefully utilize CDoH terminology. Facilitation via revised, consistent and operational definition of CDoH would assist. Social, political, commercial and economic structures and relations of CDoH are under-theorized. Systematic approaches to identifying, describing, and disrupting these are required to improve global health. BioMed Central 2020-06-29 /pmc/articles/PMC7325018/ /pubmed/32600398 http://dx.doi.org/10.1186/s12889-020-09126-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article de Lacy-Vawdon, Cassandra Livingstone, Charles Defining the commercial determinants of health: a systematic review |
title | Defining the commercial determinants of health: a systematic review |
title_full | Defining the commercial determinants of health: a systematic review |
title_fullStr | Defining the commercial determinants of health: a systematic review |
title_full_unstemmed | Defining the commercial determinants of health: a systematic review |
title_short | Defining the commercial determinants of health: a systematic review |
title_sort | defining the commercial determinants of health: a systematic review |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325018/ https://www.ncbi.nlm.nih.gov/pubmed/32600398 http://dx.doi.org/10.1186/s12889-020-09126-1 |
work_keys_str_mv | AT delacyvawdoncassandra definingthecommercialdeterminantsofhealthasystematicreview AT livingstonecharles definingthecommercialdeterminantsofhealthasystematicreview |